By: [email protected], Content Manager, Swoop
Building custom audience segments can help marketers better reach consumers.
[email protected], SVP of sales at Swoop, explains how pharma brands can leverage condition-specific patient segments to connect with more relevant consumer audiences online. Carr delves into the privacy changes being made by branded technology walled gardens and why strengthening targeting via a custom-built patient audience segment puts advertisers in a more favorable position as those shifts occur.
About the Author
[email protected]
Content Manager
| |
|
Emilie has nearly a decade of experience in marketing, writing, research and strategy for the pharmaceutical industry. She has contributed to top pharmaceutical publications including American Pharmaceutical Review, European Pharmaceutical Review, Pharmaceutical Manufacturing, Manufacturing Chemist, Pharmaceutical Outsourcing, Specialty Chemicals, and Contract Pharma. Prior to joining Swoop/IPM.ai, Emilie served as Strategic Content Manager and Managing Editor for Pharma’s Almanac where she lent her voice to some of the industry’s top players including GSK, MilliporeSigma and ThermoFisher Scientific.
|
Swoop
Improving Patient Outcomes
Swoop improves patient outcomes by connecting the signals that drive earlier diagnosis, better treatment decisions, and sustained adherence.
The integrated, privacy-by-design platform enables life sciences companies to drive measurable patient and commercial outcomes with actionable intelligence — spanning patient and HCP audience targeting, community engagement, AI-powered web solutions, coordinated omnichannel activation, and prescription fulfillment.
